Board Change • Jun 25
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Chairman of the Board Greg Dingizian is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Feb 20
Doxa AB (publ), Annual General Meeting, Apr 21, 2026 Doxa AB (publ), Annual General Meeting, Apr 21, 2026. Location: malmo Sweden Announcement • Mar 20
Doxa AB (publ), Annual General Meeting, Apr 29, 2025 Doxa AB (publ), Annual General Meeting, Apr 29, 2025. New Risk • Sep 02
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 182% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (38% average weekly change). Shareholders have been substantially diluted in the past year (182% increase in shares outstanding). Minor Risk Revenue is less than US$5m (kr17m revenue, or US$1.6m). Reported Earnings • Aug 23
Second quarter 2024 earnings released: EPS: kr0.01 (vs kr0.64 in 2Q 2023) Second quarter 2024 results: EPS: kr0.01 (down from kr0.64 in 2Q 2023). Net income: kr6.00m (down 97% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings. New Risk • Jun 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (118% increase in shares outstanding). Minor Risk Revenue is less than US$5m (kr14m revenue, or US$1.3m). Reported Earnings • Apr 30
First quarter 2024 earnings released: kr0.56 loss per share (vs kr0.094 loss in 1Q 2023) First quarter 2024 results: kr0.56 loss per share (further deteriorated from kr0.094 loss in 1Q 2023). Net loss: kr320.1m (loss widened kr292.5m from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings. Announcement • Apr 12
Doxa AB (publ) announced that it has received SEK 200 million in funding Doxa AB (publ) announced a private placement of shares at a price of SEK 2.85 per share for the gross proceeds of SEK 200,000,000 on April 10, 2024. The directed share issue was directed to Swedish and international institutional investors and was subscribed for by new and existing shareholders. The transaction is subjected to approval from EGM . Recent Insider Transactions • Feb 19
Independent Director recently bought €190k worth of stock On the 16th of February, Greg Dingizian bought around 692k shares on-market at roughly €0.27 per share. This transaction amounted to 1.2% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €826k more in shares than they have sold in the last 12 months. Reported Earnings • Feb 16
Full year 2023 earnings released: EPS: kr1.40 (vs kr0.14 loss in FY 2022) Full year 2023 results: EPS: kr1.40 (up from kr0.14 loss in FY 2022). Revenue: kr563.0m (up kr557.7m from FY 2022). Net income: kr542.9m (up kr582.8m from FY 2022). Profit margin: 96% (up from net loss in FY 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 20
Third quarter 2023 earnings released: EPS: kr1.23 (vs kr0.028 loss in 3Q 2022) Third quarter 2023 results: EPS: kr1.23 (up from kr0.028 loss in 3Q 2022). Revenue: kr562.0m (up kr560.6m from 3Q 2022). Net income: kr560.6m (up kr568.8m from 3Q 2022). Profit margin: 100% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. New Risk • Oct 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.2% average weekly change). Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Revenue is less than US$1m (kr5.7m revenue, or US$517k). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1,095% net profit margin). Recent Insider Transactions • Jul 26
Independent Chairman recently bought €65k worth of stock On the 24th of July, Per Ekelund bought around 181k shares on-market at roughly €0.36 per share. This transaction amounted to 6.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €455k. Per has been a buyer over the last 12 months, purchasing a net total of €108k worth in shares. New Risk • Jul 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 277% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Revenue is less than US$1m (kr5.7m revenue, or US$549k). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1,095% net profit margin). Reported Earnings • Jul 19
Second quarter 2023 earnings released: EPS: kr0.64 (vs kr0.31 in 2Q 2022) Second quarter 2023 results: EPS: kr0.64 (up from kr0.31 in 2Q 2022). Revenue: kr237.7m (up kr236.0m from 2Q 2022). Net income: kr213.7m (up 135% from 2Q 2022). Profit margin: 90% (down from 5,341% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. New Risk • Jun 12
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (kr5.9m revenue, or US$548k). Board Change • May 24
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. 1 independent director (4 non-independent directors). Director Christian Lindgren is the most experienced director on the board, commencing their role in 2019. Independent Vice Chairman Per Ekelund was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Recent Insider Transactions • May 15
Insider recently bought €455k worth of stock On the 10th of May, Peter Strand bought around 1m shares on-market at roughly €0.45 per share. This transaction amounted to 20% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • May 02
First quarter 2023 earnings released: kr0.09 loss per share (vs kr0.029 loss in 1Q 2022) First quarter 2023 results: kr0.09 loss per share (further deteriorated from kr0.029 loss in 1Q 2022). Net loss: kr27.6m (loss widened 294% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 17
Full year 2022 earnings released: kr0.14 loss per share (vs kr0.67 profit in FY 2021) Full year 2022 results: kr0.14 loss per share (down from kr0.67 profit in FY 2021). Net loss: kr39.9m (down 152% from profit in FY 2021). Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Announcement • Dec 17
Lifco AB (publ) (OM:LIFCO B) acquired Doxa Dental Ab. Lifco AB (publ) (OM:LIFCO B) acquired Doxa Dental Ab on December 16, 2022.
Lifco AB (publ) (OM:LIFCO B) completed the acquisition of Doxa Dental Ab on December 16, 2022. Board Change • Nov 16
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Independent Director Ingrid Heiman is the most experienced director on the board, commencing their role in 2015. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 30
Third quarter 2022 earnings released: kr0.03 loss per share (vs kr0.045 loss in 3Q 2021) Third quarter 2022 results: kr0.03 loss per share. Net loss: kr8.20m (loss widened 26% from 3Q 2021). Reported Earnings • Jul 23
Second quarter 2022 earnings released: EPS: kr0.31 (vs kr0.067 loss in 2Q 2021) Second quarter 2022 results: EPS: kr0.31 (up from kr0.067 loss in 2Q 2021). Revenue: kr96.5m (up kr92.6m from 2Q 2021). Net income: kr90.8m (up kr95.2m from 2Q 2021). Profit margin: 94% (up from net loss in 2Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Announcement • May 20
Doxa AB (publ) (OM:DOXA) entered into agreement to acquire Retail property Stridsyxan 2 in Malmo from Swedish Logistic Property AB (OM:SLP B) for approximately SEK144 million. Doxa AB (publ) (OM:DOXA) entered into agreement to acquire Retail property Stridsyxan 2 in Malmo from Swedish Logistic Property AB (OM:SLP B) for approximately SEK 144 million on May 19, 2022. Reported Earnings • May 01
First quarter 2022 earnings released: kr0.03 loss per share (vs kr0.048 loss in 1Q 2021) First quarter 2022 results: kr0.03 loss per share. Revenue: kr500.0k (down 87% from 1Q 2021). Net loss: kr7.00m (loss widened 133% from 1Q 2021). Board Change • Apr 27
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Independent Director Ingrid Heiman is the most experienced director on the board, commencing their role in 2015. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 12
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: kr0.67 (up from kr0.24 loss in FY 2020). Revenue: kr121.3m (up kr111.5m from FY 2020). Net income: kr76.2m (up kr89.9m from FY 2020). Profit margin: 63% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 04
Doxa AB (publ) (OM : DOXA) (559013) acquired Sundsbron Fastighets AB from Brorman Fastigheter AB. Doxa AB (publ) (OM : DOXA) (559013) acquired Sundsbron Fastighets AB from Brorman Fastigheter AB on February 3, 2022. Thereby the Malmö Skottspolen 1 property and the site-leasehold rights to Malmö Vildanden 9, Malmö Slagan 3 and Malmö Karlsvik 6, will be transfered to Doxa AB (publ). Christer Hagberg of Advokatfirman Lindahl acted as legal advisor to Brorman Fastigheter AB.
Doxa AB (publ) (OM : DOXA) (559013) completed the acquisition of Sundsbron Fastighets AB from Brorman Fastigheter AB on February 3, 2022. Reported Earnings • Oct 30
Third quarter 2021 earnings released Third quarter 2021 results: Net loss: kr6.50m (loss widened 59% from 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 170 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 24
First quarter 2021 earnings released The company reported a soft first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2021 results: Revenue: kr3.90m (up 5.4% from 1Q 2020). Net loss: kr3.00m (loss widened 7.1% from 1Q 2020). Reported Earnings • Feb 23
Full year 2020 earnings released: kr0.24 loss per share (vs kr0.20 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: kr10.3m (down 49% from FY 2019). Net loss: kr13.7m (loss widened 22% from FY 2019). Is New 90 Day High Low • Nov 20
New 90-day high: €0.22 The company is up 9.0% from its price of €0.20 on 21 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 6.0% over the same period. Announcement • Nov 06
Doxa AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 15 million. Doxa AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 15 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 7,142,857
Price\Range: SEK 2.1
Transaction Features: Rights Offering Reported Earnings • Oct 20
Third quarter earnings released Over the last 12 months the company has reported total losses of kr11.3m, with losses narrowing by 14% from the prior year. Total revenue was kr13.5m over the last 12 months, down 25% from the prior year.